8-K: Oragenics CEO to Present at Sequire Investor Summit

Oragenics, Inc. announced its CEO will present at the Sequire Investor Summit on January 20, 2026, utilizing a new investor presentation.

Summary

• Oragenics, Inc. will use a new investor presentation, attached as Exhibit 99.1, on January 20, 2026.
• The presentation will be delivered by the Company's CEO at the Sequire Investor Summit.
• The presentation materials will also be available under the 'Presentations' tab in the 'News and Media' section of the company's website, www.oragenics.com.
• Information contained in the presentation is summary in nature and should be considered in the context of the Company's other SEC filings and public announcements.
• The Company does not undertake a duty to publicly update or revise the information contained in this specific report.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The filing announces a routine investor relations event, indicating ongoing engagement with the financial community and transparency by making presentation materials available. No significant positive or negative news is disclosed within the 8-K itself, but investor presentations are generally seen as a positive step for communication.

Positives

• Engagement with the investment community through a CEO presentation at the Sequire Investor Summit.
• Increased transparency by making the investor presentation publicly available on the company's website.

Risks

• The information presented in Item 7.01 and Exhibit 99.1 is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, limiting liability unless specifically incorporated by reference into another filing.

Future Outlook

The filing itself does not contain specific forward-looking statements or guidance, beyond the expectation of using the presentation at the summit.

Management Comments

• Oragenics, Inc. expects to use the presentation attached hereto as Exhibit 99.1 in connection with a presentation by the Company's CEO at the Sequire Investor Summit.

Industry Context

This announcement represents a standard investor relations activity for a publicly traded company, aimed at communicating updates and strategy to the investment community and maintaining transparency.

Stakeholder Impact

• Shareholders/Investors: Provides access to updated company information through the investor presentation and an opportunity to hear from the CEO.
• General Public: Increased transparency regarding company activities and communications.

Next Steps

• The CEO will present at the Sequire Investor Summit on January 20, 2026.
• The investor presentation (Exhibit 99.1) will be made available on the company's website.

Key Dates

Recommendation

The filing is a routine 8-K announcing an upcoming investor presentation by the CEO. It does not contain any new material financial results, strategic shifts, or operational updates that would warrant a change in investment recommendation. Investors should review the actual presentation (Exhibit 99.1) for any potentially market-moving information.

Keywords

Oragenics, OGEN, Investor Summit, SEC Filing, Investor Presentation, Regulation FD, Corporate Disclosure